Published in J Immunol on April 15, 2009
Asthma and allergic inflammation. Cell (2010) 2.21
Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity (2013) 1.62
Protective and pathological roles of mast cells and basophils. Nat Rev Immunol (2013) 1.54
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2010) 1.52
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol (2014) 1.14
Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. J Immunol (2011) 1.12
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev (2012) 1.11
B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiation. J Immunol (2014) 1.07
The roles of mast cells in anticancer immunity. Cancer Immunol Immunother (2012) 0.98
Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol (2012) 0.96
Mast cell: an emerging partner in immune interaction. Front Immunol (2012) 0.95
Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol Lett (2009) 0.95
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? Front Immunol (2012) 0.93
Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological response. J Transl Med (2012) 0.91
Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol (2011) 0.90
Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol (2011) 0.90
The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling. Front Immunol (2012) 0.90
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol (2014) 0.88
Mast cells impair the development of protective anti-tumor immunity. Cancer Immunol Immunother (2012) 0.88
Pharmacotherapy of systemic sclerosis. Expert Opin Pharmacother (2010) 0.86
Mast cells in allergic asthma and beyond. Yonsei Med J (2010) 0.85
Tetraspanins in mast cells. Front Immunol (2012) 0.84
Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion. Transfusion (2011) 0.83
Mast Cells as Regulators of T Cell Responses. Front Immunol (2015) 0.83
New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol (2009) 0.83
Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation. J Cell Biol (2015) 0.82
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci (2012) 0.82
Cognate interactions between mast cells and helper T lymphocytes. Self Nonself (2010) 0.82
Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases. J Allergy Clin Immunol (2016) 0.82
The meninges: new therapeutic targets for multiple sclerosis. Transl Res (2014) 0.81
Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells. J Biol Chem (2011) 0.81
Mast cell-directed recruitment of MHC class II positive cells and eosinophils towards mesenteric lymphatic vessels in adulthood and elderly. Lymphat Res Biol (2014) 0.80
Mast cell and autoimmune diseases. Mediators Inflamm (2015) 0.80
Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression. J Leukoc Biol (2013) 0.78
Mast cells: multitalented facilitators of protection against bacterial pathogens. Expert Rev Clin Immunol (2013) 0.78
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation. Oncotarget (2014) 0.77
Antigen/IgG immune complex-primed mucosal mast cells mediate antigen-specific activation of co-cultured T cells. Immunology (2015) 0.76
Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells. BMC Immunol (2014) 0.76
Roles and relevance of mast cells in infection and vaccination. J Biomed Res (2015) 0.75
IL-33 promotes MHC class II expression in murine mast cells. Immun Inflamm Dis (2015) 0.75
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
TLR signaling. Semin Immunol (2007) 8.16
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity (2003) 5.52
Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature (2006) 5.49
Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell (1997) 2.78
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 2.73
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med (2000) 2.46
Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity (1996) 2.28
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest (2002) 2.22
DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity (1995) 2.10
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med (2000) 2.00
Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol (2006) 1.97
Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol (2003) 1.86
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell (1987) 1.74
An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol (2000) 1.47
Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A (2005) 1.47
Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol (1983) 1.42
Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol (1993) 1.25
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem (2007) 1.23
Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J (2006) 1.21
Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis (1990) 1.18
Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun (2004) 1.18
Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood (2004) 1.15
Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol (2005) 1.12
Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest (1998) 1.09
cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol (2001) 1.07
The role of mast cells in allergy and autoimmunity. Curr Opin Immunol (2002) 1.06
Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol (2000) 1.04
Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol (1996) 1.04
Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol (1994) 1.04
Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcepsilonRI signaling in mast cells. Mol Cell Biol (2006) 1.01
Reconstitution of mucosal mast cells in W/WV mice by adoptive transfer of bone marrow-derived cultured mast cells and its effects on the protective capacity to Strongyloides ratti-infection. Parasite Immunol (1987) 1.00
Indirect involvement of allergen-captured mast cells in antigen presentation. Blood (2007) 1.00
Prolonged expulsion of adult Trichinella spiralis and eosinophil infiltration in mast cell-deficient W/Wv mice. J Helminthol (1985) 0.95
MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation. J Leukoc Biol (1999) 0.95
Mast cells as effector cells: a co-stimulating question. Trends Immunol (2007) 0.90
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis. J Immunol (2006) 0.89
Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol (1995) 0.89
Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. J Leukoc Biol (1998) 0.87
Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics (2005) 0.85
FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology (1999) 0.81
H2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 mice. J Biol Chem (2001) 0.79
Dynamics of mast cells in lymph node following antigenic stimulation. Anat Histol Embryol (2004) 0.77
Role of lipopolysaccharide and IL-4 in control of transcription of the class II A alpha gene. J Immunol (1991) 0.77
The lineage decisions of helper T cells. Nat Rev Immunol (2002) 10.61
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol (2008) 10.26
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol (2005) 8.27
Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science (2003) 7.75
Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science (2007) 7.64
T cell activation. Annu Rev Immunol (2009) 7.40
The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med (2003) 5.28
The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity (2012) 4.32
MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol (2009) 4.28
Quality of care is associated with survival in vulnerable older patients. Ann Intern Med (2005) 4.05
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science (2008) 4.04
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol (2006) 3.73
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med (2007) 3.67
A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity (2009) 3.66
Multimorbidity is associated with better quality of care among vulnerable elders. Med Care (2007) 3.63
Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med (2005) 3.62
Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science (2003) 3.60
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science (2012) 3.39
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood (2010) 3.35
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 3.09
KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity (2009) 2.90
Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol (2002) 2.87
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol (2011) 2.76
Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol (2010) 2.63
The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity (2006) 2.55
The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity (2012) 2.52
Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol (2006) 2.43
A practice-based intervention to improve primary care for falls, urinary incontinence, and dementia. J Am Geriatr Soc (2009) 2.36
Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity (2011) 2.34
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell (2010) 2.29
SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity (2004) 2.18
Adaptors as central mediators of signal transduction in immune cells. Nat Immunol (2003) 2.13
Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol (2007) 2.10
Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat Immunol (2003) 1.98
The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity (2002) 1.89
IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J Immunol (2006) 1.86
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med (2009) 1.86
Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell (2002) 1.81
Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol (2003) 1.80
Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc Natl Acad Sci U S A (2007) 1.77
Nuclear repositioning marks the selective exclusion of lineage-inappropriate transcription factor loci during T helper cell differentiation. Eur J Immunol (2004) 1.76
Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest (2011) 1.75
The precursors of memory: models and controversies. Nat Rev Immunol (2009) 1.75
AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood (2010) 1.75
Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity (2008) 1.72
CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity. Immunity (2008) 1.72
The quality of medical care provided to vulnerable older patients with chronic pain. J Am Geriatr Soc (2004) 1.67
Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol (2009) 1.64
A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood (2011) 1.60
Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol (2010) 1.59
Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol Cell Biol (2006) 1.55
The effect of a quality improvement initiative on the quality of other aspects of health care: the law of unintended consequences? Med Care (2007) 1.54
Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol Rev (2006) 1.51
Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell (2006) 1.50
GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48
Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol (2005) 1.48
STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J Immunol (2004) 1.47
Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanisms. J Immunol (2010) 1.46
Predictors of overall quality of care provided to vulnerable older people. J Am Geriatr Soc (2005) 1.45
The SLP-76 family of adapter proteins. Semin Immunol (2004) 1.44
The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1. Mol Cell Biol (2006) 1.43
Detection and management of falls and instability in vulnerable elders by community physicians. J Am Geriatr Soc (2004) 1.43
CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J Immunol (2005) 1.42
Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood (2009) 1.42
Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol (2006) 1.41
Quality of osteoarthritis care for community-dwelling older adults. Arthritis Rheum (2006) 1.37
Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett (2008) 1.37
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. J Immunol (2011) 1.36
Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection. J Exp Med (2005) 1.34
B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34
Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol (2004) 1.34
Divergent transcriptional programming of class-specific B cell memory by T-bet and RORα. Nat Immunol (2012) 1.34
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J Exp Med (2013) 1.29
Functional hierarchy of the N-terminal tyrosines of SLP-76. J Immunol (2006) 1.29
Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell (2009) 1.28
CD4+CD25+ regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen. J Immunol (2008) 1.27
Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling. J Exp Med (2002) 1.24
Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination. J Exp Med (2009) 1.24
The actin cloud induced by LFA-1-mediated outside-in signals lowers the threshold for T-cell activation. Blood (2006) 1.23
Phospholipase cbeta is critical for T cell chemotaxis. J Immunol (2007) 1.22
Roles of the proline-rich domain in SLP-76 subcellular localization and T cell function. J Biol Chem (2004) 1.21
Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J Biol Chem (2002) 1.20
Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. J Exp Med (2007) 1.20
T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool. Blood (2010) 1.19
SLP-76 regulates Fcgamma receptor and integrin signaling in neutrophils. Immunity (2003) 1.17
Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases. Cancer Res (2013) 1.16
Cutting Edge: Innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter. J Immunol (2004) 1.16
Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells. J Immunol (2011) 1.16
Comparison of administrative data and medical records to measure the quality of medical care provided to vulnerable older patients. Med Care (2006) 1.15
Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J Immunol (2010) 1.14
CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J Immunol (2004) 1.13
Compartmentalization of ITAM and integrin signaling by adapter molecules. Immunol Rev (2007) 1.11